Search

everythinglearnresearchcommunity

for

Search:↓

The new gel with Zinc Oxide nanoparticles and finasteride shows promise for treating hair loss when applied to the skin.

The lotion with specific plant extracts effectively increased hair growth and improved hair cycle in subjects after 3 months.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Researchers developed a new method to deliver molecules to hair follicles to manage hair growth without damaging surrounding skin.

PRP may help treat hair loss, but results vary.

Smaller particles of the drug carrier penetrated skin better, with 300 nm size being best for targeting hair follicles.

Combining lifestyle changes with personalized medication is crucial for better managing obesity in PCOS.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

New treatments like plant extracts, nanocarriers, and 3D bioprinting show promise for hair loss, but more research is needed.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Minoxidil nanoparticles significantly boost hair growth in mice compared to regular minoxidil.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Targeting Keratin 17 may help overcome cancer therapy resistance.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Blocking a protein called CXXC5 with a specific peptide can stimulate hair regrowth and new hair growth in wounds.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

A new engineered treatment shows promise in curing heart fibrosis.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Hidradenitis suppurativa is a skin condition possibly caused by hair follicle issues, with treatments focusing on infection and inflammation.

Targeting ornithine decarboxylase can help prevent skin cancer.

Selective photothermolysis can target sebaceous glands and may treat acne effectively.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.